Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine
Pharmaceuticals · 31.08.2024 · 17 (9) · 1157
DOI: 10.3390/ph17091157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 31.08.2024. Verfasst von Shiwei Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 6111…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Szechwan lovage rhizome (SLR, the rhizome of Ligusticum chuanxiong Hort., Chuanxiong in Chinese transliteration) is one Chinese materia medica (CMM) commonly used to activate blood circulation and remove blood stasis. SLR is applicable to most blood stasis syndromes. It has significant clinical efficacy in relation to human diseases of the cardiocerebrovascular system, nervous system, respiratory system, digestive system, urinary system, etc. Apart from China, SLR is also used in Singapore, Malaysia, the European Union, and the United States of America. However, the current chemical markers in pharmacopeia or monography for the quality assessment of SLR are not well characterized or specifically characterized, nor do they fully reflect the medicinal efficacy of SLR, resulting in the quality of SLR not being effectively controlled. CMM can only have medicinal efficacy when they are applied in vivo to an organism. The intensity of their pharmaceutical activities can more directly represent the quality of CMM. Therefore, the chemical constituents and pharmacological actions of SLR are reviewed in this paper. In order to demonstrate the medicinal efficacy of SLR in promoting blood circulation and removing blood stasis, bioassay methods are put forward to evaluate the pharmaceutical activities of SLR to improve hemorheology, hemodynamics, and vascular microcirculation, as well as its anti-platelet aggregation and anticoagulation properties. Through comprehensive analyses of these pharmaceutical properties, the quality and therapeutic value of SLR are ascertained.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Research Institute of Chinese Medicines as Drug & Food, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Sichuan Institute for Drug Control (Sichuan Testing Center of Medical Devices), Chengdu 611731, China.
- Centre for Natural Products Discovery, School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
- NICM Health Research Institute, Western Sydney University, Sydney, NSW 1797, Australia.
ORCID-Profile: Shiwei Huang, Kelvin Chan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, S., Chen, J., Liu, X., Xing, C., Zhao, L., Chan, K., & Lu, G. (2024). Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine. Pharmaceuticals, 17(9), 1157. https://doi.org/10.3390/ph17091157
Vancouver
Huang S, Chen J, Liu X, Xing C, Zhao L, Chan K, et al. Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine. Pharmaceuticals. 2024;17(9):1157. doi:10.3390/ph17091157
BibTeX
@article{Huang2024,
author = {Huang, Shiwei and Chen, Jiamei and Liu, Xiaohua and Xing, Chunxin and Zhao, Lu and Chan, Kelvin and Lu, Guanghua},
title = {Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {9},
pages = {1157},
doi = {10.3390/ph17091157}
}
EUVIMED